| UniProt ID | KPCB_MOUSE | |
|---|---|---|
| UniProt AC | P68404 | |
| Protein Name | Protein kinase C beta type | |
| Gene Name | Prkcb | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 671 | |
| Subcellular Localization |
Cytoplasm. Nucleus. Membrane Peripheral membrane protein. |
|
| Protein Description | Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase involved in various cellular processes such as regulation of the B-cell receptor (BCR) signalosome, oxidative stress-induced apoptosis, androgen receptor-dependent transcription regulation, insulin signaling and endothelial cells proliferation. Plays a key role in B-cell activation by regulating BCR-induced NF-kappa-B activation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11/CARMA1 at 'Ser-559', 'Ser-644' and 'Ser-652'. Phosphorylation induces CARD11/CARMA1 association with lipid rafts and recruitment of the BCL10-MALT1 complex as well as MAP3K7/TAK1, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. Plays a direct role in the negative feedback regulation of the BCR signaling, by down-modulating BTK function via direct phosphorylation of BTK at 'Ser-180', which results in the alteration of BTK plasma membrane localization and in turn inhibition of BTK activity. Involved in apoptosis following oxidative damage: in case of oxidative conditions, specifically phosphorylates 'Ser-36' of isoform p66Shc of SHC1, leading to mitochondrial accumulation of p66Shc, where p66Shc acts as a reactive oxygen species producer. Acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and specifically mediating phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag for epigenetic transcriptional activation that prevents demethylation of histone H3 'Lys-4' (H3K4me) by LSD1/KDM1A. In insulin signaling, may function downstream of IRS1 in muscle cells and mediate insulin-dependent DNA synthesis through the RAF1-MAPK/ERK signaling cascade. May participate in the regulation of glucose transport in adipocytes by negatively modulating the insulin-stimulated translocation of the glucose transporter SLC2A4/GLUT4. Under high glucose in pancreatic beta-cells, is probably involved in the inhibition of the insulin gene transcription, via regulation of MYC expression. In endothelial cells, activation of PRKCB induces increased phosphorylation of RB1, increased VEGFA-induced cell proliferation, and inhibits PI3K/AKT-dependent nitric oxide synthase (NOS3/eNOS) regulation by insulin, which causes endothelial dysfunction. Also involved in triglyceride homeostasis. Phosphorylates ATF2 which promotes cooperation between ATF2 and JUN, activating transcription (By similarity).. | |
| Protein Sequence | MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADPAAGPP ------CCCCCCCCC | 31.34 | - | |
| 11 | Phosphorylation | PAAGPPPSEGEESTV CCCCCCCCCCCHHHH | 65.10 | 22817900 | |
| 16 | Phosphorylation | PPSEGEESTVRFARK CCCCCCHHHHHHHHH | 28.09 | - | |
| 17 | Phosphorylation | PSEGEESTVRFARKG CCCCCHHHHHHHHHH | 20.98 | - | |
| 48 | Phosphorylation | ARFFKQPTFCSHCTD HHHHCCCCCCCHHHH | 34.48 | - | |
| 50 | S-palmitoylation | FFKQPTFCSHCTDFI HHCCCCCCCHHHHCH | 2.74 | 28680068 | |
| 68 | Ubiquitination | GKQGFQCQVCCFVVH CCCCCEECEEEEEEE | 22.09 | 27667366 | |
| 70 | Ubiquitination | QGFQCQVCCFVVHKR CCCEECEEEEEEECC | 0.39 | 27667366 | |
| 86 | S-palmitoylation | HEFVTFSCPGADKGP CEEEEEECCCCCCCC | 2.92 | 28680068 | |
| 103 | Ubiquitination | DDPRSKHKFKIHTYS CCCCCCCEEEEEECC | 52.68 | 27667366 | |
| 186 | Ubiquitination | DAKNLVPMDPNGLSD CHHHCCCCCCCCCCC | 11.88 | 27667366 | |
| 195 | Phosphorylation | PNGLSDPYVKLKLIP CCCCCCCCEEEEECC | 18.40 | 25521595 | |
| 197 (in isoform 2) | Ubiquitination | - | 33.78 | 22790023 | |
| 197 | Ubiquitination | GLSDPYVKLKLIPDP CCCCCCEEEEECCCC | 33.78 | 22790023 | |
| 198 | Ubiquitination | LSDPYVKLKLIPDPK CCCCCEEEEECCCCC | 3.78 | 27667366 | |
| 199 (in isoform 2) | Ubiquitination | - | 38.36 | 22790023 | |
| 199 | Ubiquitination | SDPYVKLKLIPDPKS CCCCEEEEECCCCCC | 38.36 | 22790023 | |
| 205 (in isoform 2) | Ubiquitination | - | 74.39 | 22790023 | |
| 205 | Ubiquitination | LKLIPDPKSESKQKT EEECCCCCCCCCCCC | 74.39 | 22790023 | |
| 206 | Phosphorylation | KLIPDPKSESKQKTK EECCCCCCCCCCCCC | 53.11 | 25521595 | |
| 208 | Phosphorylation | IPDPKSESKQKTKTI CCCCCCCCCCCCCEE | 47.69 | 29899451 | |
| 212 | Phosphorylation | KSESKQKTKTIKCSL CCCCCCCCCEEEEEC | 30.81 | 28059163 | |
| 216 (in isoform 2) | Ubiquitination | - | 24.01 | 22790023 | |
| 216 | Ubiquitination | KQKTKTIKCSLNPEW CCCCCEEEEECCCCC | 24.01 | 22790023 | |
| 217 | S-nitrosocysteine | QKTKTIKCSLNPEWN CCCCEEEEECCCCCC | 5.03 | - | |
| 217 | S-nitrosylation | QKTKTIKCSLNPEWN CCCCEEEEECCCCCC | 5.03 | 24895380 | |
| 232 | Ubiquitination | ETFRFQLKESDKDRR CEEEEEECCCCCCCC | 44.37 | 27667366 | |
| 233 | Ubiquitination | TFRFQLKESDKDRRL EEEEEECCCCCCCCE | 73.15 | 27667366 | |
| 242 | Ubiquitination | DKDRRLSVEIWDWDL CCCCCEEEEEEECCC | 7.97 | 27667366 | |
| 250 | Phosphorylation | EIWDWDLTSRNDFMG EEEECCCCCCCCHHH | 24.14 | - | |
| 279 | Phosphorylation | DGWFKLLSQEEGEYF CHHHHHCCCCCCCCC | 46.08 | - | |
| 304 | Ubiquitination | GNEELRQKFERAKIG CCHHHHHHHHHHHCC | 42.64 | 22790023 | |
| 304 (in isoform 2) | Ubiquitination | - | 42.64 | 22790023 | |
| 314 | Phosphorylation | RAKIGQGTKAPEEKT HHHCCCCCCCCCHHC | 19.02 | - | |
| 315 | Ubiquitination | AKIGQGTKAPEEKTA HHCCCCCCCCCHHCC | 69.62 | 27667366 | |
| 320 | Ubiquitination | GTKAPEEKTANTISK CCCCCCHHCCCCHHC | 51.80 | 22790023 | |
| 320 (in isoform 2) | Ubiquitination | - | 51.80 | 22790023 | |
| 324 | Phosphorylation | PEEKTANTISKFDNN CCHHCCCCHHCCCCC | 24.94 | - | |
| 327 | Ubiquitination | KTANTISKFDNNGNR HCCCCHHCCCCCCCC | 53.54 | 27667366 | |
| 362 (in isoform 2) | Ubiquitination | - | 63.21 | 22790023 | |
| 362 | Ubiquitination | KVMLSERKGTDELYA HHEECCCCCCCCEEE | 63.21 | 22790023 | |
| 371 | Ubiquitination | TDELYAVKILKKDVV CCCEEEEEEECCCEE | 33.86 | 27667366 | |
| 449 | Ubiquitination | HAVFYAAEIAIGLFF HHHHHHHHHHHHHHH | 25.45 | 27667366 | |
| 459 | Phosphorylation | IGLFFLQSKGIIYRD HHHHHHHCCCEEEEE | 34.69 | - | |
| 465 | Methylation | QSKGIIYRDLKLDNV HCCCEEEEEEEECCE | 32.17 | 30988843 | |
| 497 | Phosphorylation | ENIWDGVTTKTFCGT CCCCCCCCCCCCCCC | 28.27 | 20415495 | |
| 498 | Phosphorylation | NIWDGVTTKTFCGTP CCCCCCCCCCCCCCC | 26.19 | 20415495 | |
| 500 | Phosphorylation | WDGVTTKTFCGTPDY CCCCCCCCCCCCCCC | 23.28 | 24925903 | |
| 504 | Phosphorylation | TTKTFCGTPDYIAPE CCCCCCCCCCCCCCH | 17.73 | 24925903 | |
| 507 | Phosphorylation | TFCGTPDYIAPEIIA CCCCCCCCCCCHHHC | 10.53 | 25619855 | |
| 515 | Phosphorylation | IAPEIIAYQPYGKSV CCCHHHCCCCCCCCH | 10.30 | 25619855 | |
| 518 | Phosphorylation | EIIAYQPYGKSVDWW HHHCCCCCCCCHHHH | 22.97 | 20415495 | |
| 578 | Ubiquitination | ICKGLMTKHPGKRLG HHHHHHHCCCCCCCC | 33.56 | 27667366 | |
| 618 | Ubiquitination | KEIQPPYKPKARDKR CCCCCCCCCCCCCCC | 45.90 | 27667366 | |
| 634 (in isoform 2) | Phosphorylation | - | 9.33 | 29899451 | |
| 635 | Phosphorylation | SNFDKEFTRQPVELT CCCCHHHHCCCCEEC | 29.50 | 22324799 | |
| 641 | Phosphorylation | FTRQPVELTPTDKLF HHCCCCEECCCCEEE | 7.66 | 17114649 | |
| 641 (in isoform 2) | Phosphorylation | - | 7.66 | 25521595 | |
| 642 | Phosphorylation | TRQPVELTPTDKLFI HCCCCEECCCCEEEE | 15.61 | 25521595 | |
| 644 | Phosphorylation | QPVELTPTDKLFIMN CCCEECCCCEEEEEE | 40.30 | 25521595 | |
| 654 (in isoform 2) | Phosphorylation | - | 55.29 | 22324799 | |
| 660 (in isoform 2) | Phosphorylation | - | 4.53 | 25521595 | |
| 661 | Phosphorylation | QNEFAGFSYTNPEFV CCCCCCCCCCCCCCE | 30.08 | - | |
| 662 | Phosphorylation | NEFAGFSYTNPEFVI CCCCCCCCCCCCCEE | 14.31 | 12881490 | |
| 664 (in isoform 2) | Phosphorylation | - | 26.35 | 24453211 | |
| 673 (in isoform 2) | Phosphorylation | - | 21183079 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 500 | T | Phosphorylation | Kinase | PRKCA | P20444 | GPS |
| 500 | T | Phosphorylation | Kinase | PRKCB | P68404 | GPS |
| 500 | T | Phosphorylation | Kinase | PDPK1 | Q9Z2A0 | Uniprot |
| 660 | S | Phosphorylation | Kinase | PRKCB | P68404 | GPS |
| 661 | S | Phosphorylation | Kinase | PRKCB | P68404 | GPS |
| 662 | Y | Phosphorylation | Kinase | SYK | P48025 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KPCB_MOUSE !! | ||||||
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASSSPECTROMETRY. | |
| "A Ras activation pathway dependent on Syk phosphorylation of proteinkinase C."; Kawakami Y., Kitaura J., Yao L., McHenry R.W., Kawakami Y.,Newton A.C., Kang S., Kato R.M., Leitges M., Rawlings D.J.,Kawakami T.; Proc. Natl. Acad. Sci. U.S.A. 100:9470-9475(2003). Cited for: PHOSPHORYLATION AT TYR-662. | |